Name
Purdue University Globle
NU581 FNP II Clinical – Children and Adolescent Health Focus
Prof. Name
Date
A 5-year-old child with bilateral acute otitis media (AOM), a temperature of 103.2°F (39.6°C), severe ear pain, and bulging tympanic membranes requires prompt antibiotic treatment. For a child without a penicillin allergy, high-dose amoxicillin is the recommended first-line antibiotic. Effective management also includes pain relief, caregiver education, monitoring for adverse effects, and reassessment if symptoms fail to improve within 48–72 hours. This case illustrates evidence-based pediatric prescribing, antibiotic selection, and follow-up care.
A 5-year-old male presents to a primary care clinic with acute bilateral ear pain that began one day before evaluation. His mother reports persistent crying because of the pain, minimal relief after ibuprofen, refusal to eat breakfast, and worsening symptoms.
The child has no known drug allergies, no previous history of otitis media, and no antibiotic exposure during the preceding year.
| Assessment Parameter | Clinical Finding |
|---|---|
| Age | 5 years |
| Sex | Male |
| Heart rate | 110 beats/minute |
| Respiratory rate | 28 breaths/minute |
| Tympanic temperature | 103.2°F (39.6°C) |
| Weight | 40.5 lb (18.4 kg) |
| Tympanic membranes | Bilaterally bulging, erythematous, and immobile |
| Pneumatic otoscopy | Reduced tympanic membrane mobility |
| Ear canals | Normal |
| Drug allergies | None reported |
The presence of bilateral bulging, erythematous, and immobile tympanic membranes supports the diagnosis of acute otitis media. The elevated temperature, significant otalgia, and worsening clinical condition indicate severe AOM.
Yes. Immediate antibiotic therapy is indicated for this patient.
The American Academy of Pediatrics (AAP) clinical practice guideline recommends antibiotic treatment for children with AOM who have severe signs or symptoms. Severe AOM includes moderate-to-severe otalgia, otalgia lasting at least 48 hours, or a temperature of 102.2°F (39°C) or higher (Lieberthal et al., 2013).
This child meets the criteria for severe AOM because his temperature is 103.2°F and he has substantial ear pain with worsening symptoms. Although observation may be appropriate for selected children with nonsevere AOM, watchful waiting is not the preferred approach in this case.
High-dose amoxicillin is the recommended first-line antibiotic for this child because he has no reported penicillin allergy and has not received amoxicillin during the past 30 days.
Amoxicillin is a narrow-spectrum penicillin antibiotic that provides activity against common bacterial pathogens associated with AOM. Its favorable safety profile, affordability, and availability make it an appropriate initial treatment choice.
Amoxicillin is selected because it:
Targets common bacterial causes of acute otitis media.
Has a well-established pediatric safety profile.
Is generally affordable and widely available.
Supports antimicrobial stewardship when used appropriately.
Can be administered orally in a child who can tolerate oral medication.
The APRN should confirm the child’s allergy history, medication history, weight, and ability to take oral medication before prescribing.
The AAP recommends high-dose amoxicillin at 80–90 mg/kg/day divided into two doses for appropriate children with AOM.
The child weighs 18.4 kg.
Recommended daily dose: 80–90 mg/kg/day
At 80 mg/kg/day:
80 mg × 18.4 kg = 1,472 mg/day
Divided into two doses:
1,472 mg ÷ 2 = 736 mg per dose
At 90 mg/kg/day:
90 mg × 18.4 kg = 1,656 mg/day
Divided into two doses:
1,656 mg ÷ 2 = 828 mg per dose
| Prescription Component | Recommendation |
|---|---|
| Medication | Amoxicillin |
| Dose | 80–90 mg/kg/day |
| Route | Oral |
| Frequency | Twice daily |
| Calculated dose range | 736–828 mg per dose |
| Duration | 10 days is a reasonable course for severe AOM in this case |
A commonly selected high-dose regimen is approximately 828 mg orally twice daily, corresponding to 90 mg/kg/day. The exact prescribed volume depends on the available formulation and concentration. The APRN should verify the dose against the product label and an appropriate pediatric prescribing reference before issuing the prescription.
For children with severe AOM, a 10-day treatment course is generally recommended. The clinician should use the shortest effective duration consistent with current guidelines and the patient’s clinical presentation.
Caregiver education is an important part of successful AOM treatment. The mother should understand how to administer the antibiotic, manage pain, recognize adverse effects, and identify signs that require further evaluation.
The caregiver should be instructed to:
Administer amoxicillin exactly as prescribed.
Give doses at the recommended times and use an oral syringe for liquid medication.
Complete the prescribed treatment course unless the healthcare provider directs otherwise.
Encourage fluids and age-appropriate nutrition as tolerated.
Continue appropriate pain management with acetaminophen or ibuprofen.
Avoid inserting cotton swabs, objects, or other substances into the ear canal.
Contact the healthcare provider if symptoms worsen or fail to improve.
Clinical improvement is commonly expected within 48–72 hours after starting appropriate antibiotic therapy. Ear discomfort may not disappear immediately, so pain management should continue as needed.
The caregiver should contact the APRN if the child develops worsening ear pain, persistent high fever, new symptoms, or difficulty maintaining hydration. Reassessment is particularly important if there is no meaningful improvement after 48–72 hours of antibiotic treatment.
Urgent medical evaluation is warranted if the child develops severe illness, swelling behind the ear, facial weakness, altered responsiveness, or signs of dehydration.
Amoxicillin is generally well tolerated, but caregivers should be aware of possible adverse effects.
The most common side effects include:
Nausea
Vomiting
Diarrhea
Mild abdominal discomfort
Skin rash
Gastrointestinal symptoms are often mild and may resolve during or after treatment.
Rare but important complications include serious allergic reactions and antibiotic-associated diarrhea, including Clostridioides difficile infection.
Parents should seek emergency medical attention if the child develops:
Difficulty breathing
Facial, lip, or tongue swelling
A rapidly spreading or severe rash
Fainting or signs of a severe allergic reaction
A rash should be reported to the healthcare provider, particularly if it is accompanied by fever, blistering, or mucosal involvement.
Antibiotic selection changes when a child has a documented penicillin allergy. The APRN should determine whether the reaction was mild, such as a delayed nonurticarial rash, or a serious immediate hypersensitivity reaction involving hives, angioedema, or anaphylaxis.
For children with nonsevere penicillin allergy, certain oral cephalosporins may be appropriate. For children with severe allergy or inability to tolerate oral medication, an alternative treatment plan is needed.
Cefdinir is an oral third-generation cephalosporin that may be used in selected children with penicillin allergy.
Recommended dosage: 14 mg/kg/day orally, administered once daily or divided into two doses.
For this 18.4 kg child:
14 mg × 18.4 kg = 257.6 mg/day
Possible dosing schedules include:
Approximately 258 mg once daily.
Approximately 129 mg twice daily.
A 10-day course may be used for severe AOM in this age group, based on the clinician’s assessment and current prescribing recommendations.
Potential adverse effects include diarrhea, nausea, vomiting, rash, and reddish or reddish-brown stools. Cefdinir can cause red stool discoloration, particularly when administered with iron-containing products.
Ceftriaxone is an injectable cephalosporin that may be considered when oral medication cannot be tolerated, such as in a child with persistent vomiting.
Recommended dosage: 50 mg/kg administered intramuscularly or intravenously once daily, according to the clinical situation.
For an 18.4 kg child:
50 mg × 18.4 kg = 920 mg
This corresponds to approximately 920 mg per dose.
Ceftriaxone may be administered for one to three days, depending on the clinical response and the applicable treatment recommendation. A single dose is not interchangeable with a multi-day regimen in every clinical circumstance.
Potential disadvantages include injection-site discomfort, increased cost, and the need for administration by a healthcare professional.
The APRN should individualize antibiotic treatment based on the child’s clinical condition, medical history, and likelihood of treatment success.
Important prescribing considerations include:
Severity of symptoms and physical examination findings.
Age and body weight.
Known drug allergies and previous allergic reactions.
Antibiotic exposure within the preceding 30 days.
Suspected bacterial pathogens and local resistance patterns.
Ability to tolerate oral medication.
Relevant comorbidities.
Medication adherence and caregiver understanding.
Antibiotics should not be prescribed automatically for every ear infection. Evidence-based prescribing helps reduce unnecessary adverse effects and antimicrobial resistance.
Pain relief should begin immediately because AOM can cause significant discomfort, particularly during the first 24–48 hours.
Appropriate supportive care includes:
Acetaminophen: Administer according to the child’s weight and the product’s dosing instructions.
Ibuprofen: May be used for children older than 6 months when appropriate, using weight-based dosing and avoiding use in children who are dehydrated or have relevant contraindications.
Warm compresses: A warm compress placed externally over the affected ear may provide comfort. It should not be excessively hot.
Hydration and rest: Encourage fluids and rest to support recovery.
Distraction: Age-appropriate activities may help reduce distress associated with pain.
Caregivers should never place ice directly on the skin or insert home remedies into the ear canal without medical advice. OTC medication labels should be followed carefully, and duplicate products containing acetaminophen should be avoided.
If the child returns after 48–72 hours with persistent fever, worsening ear pain, and continued abnormal tympanic membrane findings despite appropriate amoxicillin therapy, the APRN should reassess the diagnosis and treatment response.
Possible explanations include resistant bacterial organisms, an alternative diagnosis, concurrent viral illness, or inadequate medication administration.
Amoxicillin-clavulanate is recommended when initial amoxicillin therapy fails, provided there are no contraindications.
The addition of clavulanate expands coverage against certain beta-lactamase-producing organisms that may contribute to treatment failure.
For treatment failure, the high-dose amoxicillin component is commonly calculated at 90 mg/kg/day, with a clavulanate component of approximately 6.4 mg/kg/day.
For this 18.4 kg child:
Amoxicillin:
90 mg × 18.4 kg = 1,656 mg/day
Clavulanate:
6.4 mg × 18.4 kg = 117.76 mg/day
Divided into two doses, the approximate dose is:
Amoxicillin: 828 mg twice daily.
Clavulanate: 58.9 mg twice daily.
The exact prescribed amount depends on the selected formulation and its amoxicillin-to-clavulanate ratio. The clinician should select a formulation that provides the appropriate amoxicillin dose while limiting unnecessary clavulanate exposure.
A 10-day course may be appropriate for this child’s severe presentation, based on reassessment and current guidelines.
Common adverse effects include:
Diarrhea
Nausea
Vomiting
Abdominal discomfort
Rash
Diarrhea is more common with amoxicillin-clavulanate than with amoxicillin alone. Caregivers should report severe or persistent diarrhea, especially if accompanied by blood, fever, or significant abdominal pain.
A 5-year-old child with bilateral acute otitis media, a temperature of 103.2°F, bulging tympanic membranes, and severe ear pain meets criteria for immediate antibiotic therapy. High-dose amoxicillin is the recommended first-line treatment when there is no penicillin allergy or recent amoxicillin exposure.
The APRN should calculate the dose using the child’s weight, provide effective pain management, educate the caregiver about medication administration and adverse effects, and arrange reassessment if symptoms fail to improve within 48–72 hours. Cefdinir or ceftriaxone may be considered in selected penicillin-allergic children, while amoxicillin-clavulanate is an appropriate second-line option when initial amoxicillin therapy fails.
Evidence-based prescribing and close follow-up are essential to promote clinical recovery, reduce complications, and support responsible antibiotic use.
Akhavan, B. J., Khanna, N. F., & Vijhani, P. (2020). Amoxicillin. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK482250/
Garzon Maaks, D. L., Barber Starr, N., Brady, M. A., Gaylord, N. M., Driessnack, M., & Duderstadt, K. G. (2020). Burns’ pediatric primary care (7th ed.). Elsevier.
Lieberthal, A. S., Carroll, A. E., Chonmaitree, T., Ganiats, T. G., Hoberman, A., Jackson, M. A., Joffe, M. D., Miller, D. T., Rosenfeld, R. M., Sevilla, X. D., Schwartz, R. H., Thomas, P. A., & Tunkel, D. E. (2013). Clinical practice guideline: The diagnosis and management of acute otitis media. Pediatrics, 131(3), e964–e999. https://publications.aap.org/pediatrics/article/131/3/e964/31030/Clinical-Practice-Guideline-The-Diagnosis-and
Woo, T. M., & Robinson, M. V. (2020). Pharmacotherapeutics for advanced practice nurse prescribers (5th ed.). F.A. Davis.
